APTO
Aptose Biosciences Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website aptose.com
- Employees(FY) 35
- ISIN CA03835T3091
Performance
+2.5%
1W
-10.87%
1M
-41.15%
3M
-59.8%
6M
-51.57%
YTD
-84.53%
1Y
Profile
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and Tuspetinib, an oral potent myeloid kinase inhibitor that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory AML. The company also develops luxeptinib, an orally administered, and potent dual lymphoid and myeloid kinome inhibitor that is in Phase 1a/b clinical trial for treating patients with relapsed or refractory B-cell malignancies, including chronic lymphocytic leukemia, small lymphocytic lymphoma, and various non-Hodgkin's lymphomas, as well as AML and HR MDS. It has agreements with CrystalGenomics, Inc. and Hanmi Pharmaceutical Co. Ltd. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.
Technical Analysis of APTO 2024-05-03
Overview:
In analyzing the technical indicators for APTO over the last 5 days, we will delve into the trends, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.
Trend Ana...
Recent News & Updates
- 2024-05-06 04:30
- 2024-04-05 00:00
- 2024-03-26 20:26
- 2024-03-26 08:53
- 2024-03-26 04:01
- 2024-03-18 04:30
- 2024-01-31 03:01
- 2024-01-25 19:36
Why Is Aptose Biosciences (APTO) Stock Down Today?(Investorplace)
- 2024-01-25 19:00
- 2023-12-09 05:30
- 2023-11-30 03:59
- 2023-11-09 22:21
- 2023-11-09 03:17
Aptose Biosciences: Q3 Earnings Snapshot(Yahoo Finance)
- 2023-11-09 03:00
Aptose Reports Results for the Third Quarter 2023(Globenewswire)
- 2023-11-01 21:00
- 2023-10-29 21:15
- 2023-10-25 19:11
- 2023-10-22 19:30
- 2023-10-15 19:30
- 2023-09-17 19:45
Aptose to Present at the Cantor Global Healthcare Conference(Yahoo Finance)
- 2023-09-05 19:45
- 2023-08-23 19:30
- 2023-08-10 04:08
Aptose Biosciences: Q2 Earnings Snapshot(Yahoo Finance)
- 2023-08-10 04:02
Aptose Reports Results for the Second Quarter 2023(Yahoo Finance)
- 2023-07-27 04:04
- 2023-06-26 04:05
Aptose Biosciences Meets Nasdaq Minimum Bid Price Compliance(Yahoo Finance)
- 2023-06-10 00:00
Aptose Presents Highlights from Clinical Update(Yahoo Finance)
- 2023-06-04 19:30
Aptose Biosciences Provides Update on Reverse Stock Split(Yahoo Finance)
- 2023-05-30 19:30
- 2023-05-25 04:14
Aptose Enters into $25 Million Committed Equity Facility(Yahoo Finance)
Page 1 of 4
previousnext